Headaches cost world economy £140 billion a year

By Admin
Headaches and migraines are costing the worlds economy £140 billion each year, because they are under-recognised and under-diagnosed, according t...

Headaches and migraines are costing the world’s economy £140 billion each year, because they are under-recognised and under-diagnosed, according to the World Health Organisation (WHO).

The WHO says that 47 per cent of adults worldwide suffer from some sort of headache disorder and they are calling for improvements to be made on the huge impact that they have on society.

In the European Union (EU) alone 190 million working days are lost due to migraines, and the WHO says: “'the financial costs to society through lost productivity are enormous.”

To read the latest edition of Exec Digital, click here
FluPhone app could track epidemics

Superfruit cocktail has super heart benefits

Warnings over alcohol risk

The WHO's director of mental health and substance abuse disorders, Dr Shekhar Saxena, said: “Headache and migraine disorders are greatly underrated and underreported by health systems and receive too little attention.”

“Headaches can be debilitating for many people, rendering them unable to work,” Dr Saxena added.

“During migraine attacks, 90 per cent of people postpone household chores, almost three-quarters have limited ability to work and half of them miss work entirely.”

The health organisation has recently published a global report on headaches and has estimated that migraines are the most expensive brain disorder in both the EU and United States (US).

One of the most important findings that came out of the report was that migraines alone are the cause of 1.3 per cent of all disability in the world and experts believe that all headache disorders could double this figure.

“Governments must take the issue more seriously, train health personnel in headache disorder diagnosis and treatment, and ensure appropriate medication is available and used properly,” said Dr Saxena.

Last year an international scientific team found a genetic link to migraines and experts are hoping this could help to develop new treatments for migraine attacks.


Featured Articles

Johnson & Johnson: Turning supplier spend into local support

Johnson & Johnson’s Global Supplier Diversity & Inclusion team is growing spending with social enterprises around the globe to expand its impact

Seasonal Affective Disorder’s impact on health & solutions

Dr Ravi Gill & Dr. Naomi Newman-Beinart discuss Seasonal Affective Disorder and its treatments, from vitamin D spray to light therapy

CGI teams up with Totalmobile for digital healthcare service

CGI is driving efficiency in healthcare. Hear from Helena Jochberger, at Manufacturing Digital LIVE, a free virtual event on Wednesday 6th December 2023

Deloitte: generative AI can improve access to healthcare

Technology & AI

Wipro & NVIDIA’s revolutionary healthcare uses generative AI


Healthtech platform CoverSelf extends seed round to US$8.2m

Technology & AI